Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections

Ítems similars

• 1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
  per: Meng, Lina, et al.
  Publicat: (2020)
• Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy
  per: Pham, Selena N., et al.
  Publicat: (2019)
• Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia
  per: Baby, Nidhu, et al.
  Publicat: (2017)
• 2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
  per: Markoski, Nikola, et al.
  Publicat: (2019)
• 1999. Does Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus PCR Nasal Screening Decrease Time to De-Escalation of MRSA Coverage in Patients with Pneumonia?
  per: Waters, Dustin, et al.
  Publicat: (2019)